Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-046045
Filing Date
2024-11-12
Accepted
2024-11-12 09:29:25
Documents
80
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20034582_10q.htm   iXBRL 10-Q 2046517
2 EXHIBIT 10.1 ef20034582_ex10-1.htm EX-10.1 275446
3 EXHIBIT 10.2 ef20034582_ex10-2.htm EX-10.2 132863
4 EXHIBIT 10.3 ef20034582_ex10-3.htm EX-10.3 7186
5 EXHIBIT 31.1 ef20034582_ex31-1.htm EX-31.1 10293
6 EXHIBIT 31.2 ef20034582_ex31-2.htm EX-31.2 10265
7 EXHIBIT 32.1 ef20034582_ex32-1.htm EX-32.1 6614
  Complete submission text file 0001140361-24-046045.txt   8678681

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA ird-20240930.xsd EX-101.SCH 67066
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ird-20240930_cal.xml EX-101.CAL 38258
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ird-20240930_def.xml EX-101.DEF 301543
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ird-20240930_lab.xml EX-101.LAB 715602
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ird-20240930_pre.xml EX-101.PRE 449779
83 EXTRACTED XBRL INSTANCE DOCUMENT ef20034582_10q_htm.xml XML 1173959
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Opus Genetics, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 241444165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)